Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

Market Cap	15.71B
Revenue (ttm)	1.05B
Net Income (ttm)	390.43M
Shares Out	523.58M
EPS (ttm)	0.75
PE Ratio	40.23
Forward PE	41.10
Dividend	0.24 (0.80%)
Ex-Dividend Date	Jul 8, 2025

Volume	7,054,539
Average Volume	8,852,699
Open	32.68
Previous Close	31.58
Day's Range	29.97 - 32.68
52-Week Range	18.23 - 35.84
Beta	0.91
RSI	38.05
Earnings Date	Oct 26, 2025

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; and Changdian, a dust mite skin prick diagnostic kit. It also involved in the research and development of stem cells and medical artificial intelligence solutions. The company was founded in 2002 a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2002
• Employees: 1,679
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300357

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.